Safety and Immunogenicity of the Recombinant Mycobacterium bovis BCG Vaccine VPM1002 in HIV-Unexposed Newborn Infants in South Africa

Tuberculosis is a global threat to which infants are especially vulnerable. Effective vaccines are required to protect infants from this devastating disease. VPM1002, a novel recombinant Mycobacterium bovis bacillus Calmette-Guérin (BCG) vaccine previously shown to be safe and immunogenic in adults,...

詳細記述

保存先:
書誌詳細
出版年:Clin Vaccine Immunol
主要な著者: Loxton, André G., Knaul, Julia K., Grode, Leander, Gutschmidt, Andrea, Meller, Christiane, Eisele, Bernd, Johnstone, Hilary, van der Spuy, Gian, Maertzdorf, Jeroen, Kaufmann, Stefan H. E., Hesseling, Anneke C., Walzl, Gerhard, Cotton, Mark F.
フォーマット: Artigo
言語:Inglês
出版事項: American Society for Microbiology 2017
主題:
Vaccines
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5299117/
https://ncbi.nlm.nih.gov/pubmed/27974398
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/CVI.00439-16
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料